Lantheus is an American company that develops, manufactures, sells, and distributes diagnostic tools and products to help clinicians diagnose cancer, cardiovascular and other diseases. Learn the latest information and analysis on the company, LNTH stock price today, stock news, how much one share costs and other information to help you make investment decisions.
Check out Gainy to see insights on stock prices and more.
Lantheus was founded in 1956 and had an IPO in 2015. The company has headquarters in North Billerica, Massachusetts and operates worldwide.
LNTH recently crossed the mid-cap threshold and has a market capitalization of $3.8 billion, which means the company has a huge potential to grow in the future. Lantheus expects to have a record year with revenue around $700 million.
The Lantheus stock price grew over 100% this year and 70% in one week alone after reporting great fourth quarter and full year 2021 financial results on February 24, 2022, as well as after the FDA approval for a new manufacturing facility.
Check back to this page for the LNTH stock quote or download Gainy to see if LNTH fits your portfolio and investment goals, as well as other stock quotes and recommendations that fit your portfolio and interests.